Leigh Boehmer was named medical director of education for the association's expanding education initiatives at the Association of Community Cancer Centers.
The Pentecost Foundation--established in honor of teacher-turned-entrepreneur Mark Pentecost--recently made a $3 million gift to Moffitt Cancer Center to support the research at the forefront of curing his multiple myeloma.
Wafik El-Deiry was named associate dean for Oncologic Sciences at Brown University and head of the Brown-Lifespan Joint Program in Cancer Biology.
The Emory Proton Therapy Center, the first and only facility of its kind in the state of Georgia, officially opened earlier this week.
Richard Markow will retire from his position as director of the San Antonio Breast Cancer Symposium on Feb. 1. The SABCS’s 41st annual symposium is currently underway. Markow has served as director for 18 years, growing it to become one of the largest breast cancer conferences in the world. In addition to being the director... […]
The Pancreatic Cancer Collective, a strategic partnership of the Lustgarten Foundation and Stand Up To Cancer, has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of cancer researchers to explore new pancreatic cancer treatments.
Oren Cahlon, a radiation oncologist and an expert in proton therapy, was named associate deputy physician-in-chief for the Memorial Sloan Kettering Cancer Center MSK Regional Care Network.
Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant from NCI to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time.
The National Comprehensive Cancer Network announced the Abramson Cancer Center of the University of Pennsylvania will become the organization's 28th member institution.
Four new CPRIT Scholar grants totaling $16 million were awarded. The grants will support the recruitment of investigators researching cancers of the brain and digestive system as well as experts in the field of immunotherapy.
